BMN 349, a small molecule inhibitor of Z alpha-1 antitrypsin polymerization, increases secretion and reduces intrahepatic inclusions in a mouse model of disease.

Journal:
Hepatology
Published:
DOI:
10.1097/hep.0000000000001778
Affiliations:
4
Authors:
22
Go to article
Institutions Authors Share
BioMarin Pharmaceutical, Inc., United States of America (USA)
18.000000
18.000000
 0.82
UCL, United Kingdom (UK)
3.000000
 0.14
Queen's University, Canada
1.000000
 0.05
Interested in Immunology?